Power Law company profile

ImmunityBio

Biotech & Life Sciences · Culver City, United States · Founded 2014 · IPO 2015 Unicorn

ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming

Valuation

$7.61B

Market cap · May/2026

Revenue

$113M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where ImmunityBio has talent and traffic

Workforce by country

🇺🇸 United States · Culver City HQ

Book a demo for the full country breakdown

Web traffic by country

110K monthly visits
across markets

🇺🇸 United States35.5%

🇸🇦 Saudi Arabia10.7%

🇮🇳 India7.3%

🇩🇪 Germany5.5%

🇨🇦 Canada4.8%

Top 5 markets shown

Market sentiment

What the market is saying about ImmunityBio

An AI-synthesized read of the highest-engagement posts about ImmunityBio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ImmunityBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles